摘要
目的探讨药物注射止血联合氩离子凝固术治疗胃十二指肠出血的临床效果.方法选取60例2018年4月—2019年4月在该科治疗的胃十二指肠出血患者,将其随机分为对照组和观察组,各30例,对照组患者给予单独使用药物静脉注射治疗,观察组患者给予药物注射止血联合氩离子凝固术治疗,观察并比较两组患者的初次止血率、再出血率、转急诊手术率、各项住院指标、治疗有效率、并发症的发生率.结果两组患者经过治疗后,观察组初次止血率、再出血率、转急诊手术率分别为96.67%、6.67%、3.33%,对照组初次止血率、再出血率、转急诊手术率分别为70.00%、23.33%、16.67%,差异有统计学意义(x^2=12.841、8.316、6.142,P<0.05);观察组各项住院指标中的出血量为(389.31±41.36)mL、输血量为(421.69±44.76)mL、止血时间为(1.71±0.19)d、住院时间为(5.38±0.62)d,对照组各项住院指标中的出血量为(500.26±56.33)mL、输血量为(496.28±51.24)mL、止血时间为(3.22±0.28)d、住院时间为(6.59±0.77)d,差异有统计学意义(t=45.216、20.364、5.621、3.147,P<0.05);观察组患者的治疗有效率(93.33%)高于对照组(76.67%),差异有统计学意义(x^2=8.214,P<0.05);观察组并发症的发生率(6.67%)低于对照组(26.67%),差异有统计学意义(x2=9.638,P<0.05).结论在治疗胃十二指肠出血患者时,采用药物注射止血联合氩离子凝固术治疗,效果显著,止血速度更快,并发症的发生率低,更加有利于患者的康复.
Objective To investigate the clinical effect of drug injection hemostasis combined with argon ion coagulation in the treatment of gastroduodenal hemorrhage. Methods A total of 60 patients with gastroduodenal hemorrhage treated in our department from April 2018 to April 2019 were randomly divided into control group and observation group, 30 cases in each group. Patients in the control group were treated with intravenous drug alone, and patients in the observation group were given drug injection hemostasis combined with argon plasma coagulation. The primary hemostasis rate, rebleeding rate, emergency operation rate, hospitalization index, treatment efficiency and complication rate of the patients were compared between the two groups. Results After treatment, the initial hemostasis rate, rebleeding rate and emergency operation rate in the observation group were 96.67%, 6.67% and 3.33% respectively, while those in the control group were 70.00%, 23.33% and 16.67% respectively. The difference between the two groups was statistically significant (χ^2=12.841, 8.316, 6.142, P<0.05). The amount of bleeding in the observation group was (389.31±41.36) mL, the amount of blood transfusion was (421.69±44.76) mL, the time of hemostasis was (1.71±0.19) d, the length of hospitalization was (5.38±0.62) d. In the control group, the amount of bleeding was (500.26±56.33) mL, the amount of blood transfusion was (496.28±51.24) mL, the time of hemostasis was (3.22±0.28) d, and the time of hospitalization was (6.59±0.77) d. There was statistically significant difference between the two groups (t=45.216, 20.364, 5.621, 3.147, P<0.05). The effective rate of treatment in observation group (93.33%) was higher than that in control group (76.67%), and the difference between the two groups was statistically significaly(χ^2=8.214, P<0.05).The incidence of complications in observation group (6.67%) was lower than that in control group (26.67%)(χ2=9.638, P<0.05). Conclusion In the treatment of gastroduodenal hemorrhage, the effect of drug injection hemostasis combined with argon ion coagulation is significant. It speeds up hemostasis and reduces the incidence of complications, which is more conducive to the rehabilitation of patients.
作者
李莉
LI Li(Department of Gastroenterology, The Seventh People's Hospital of Changzhou, Changzhou, Jiangsu Province, 213000 China)
出处
《系统医学》
2019年第13期49-51,64,共4页
Systems Medicine
关键词
药物注射止血
氩离子凝固术
胃十二指肠出血
临床效果
Drug injection hemostasis
Argon plasma coagulation
Gastroduodenal hemorrhage
Clsinical effect
